Olink® is a company that provide innovative proteomics solutions to understand real-time biology and gain actionable insights into complex biological processes. The implementation of the Olink® platform in our services stems from our commitment to offer our customers the most comprehensive and customized proteomics solution available. Olink® enables a more targeted approach by focusing on specific proteins of interest chosen by the client. Thanks to the high specificity conferred by its antibody-based technology, it remains unaffected by the presence of highly abundant, non-informative proteins such as albumin when applied to plasma samples. Moreover, although LC-MS proteomics does not require large sample volumes – for instance, we only need 100 microliters of plasma – Olink® supports analyses using even smaller volumes (1–2 microliters). This capability is especially beneficial for example when processing residual samples from valuable matrices that have already been employed in multi-omics studies.
On the other hand, LC-MS proteomics facilitates a broader survey of the proteins present in a sample, with the potential to identify proteins not covered by the Olink® panel, across various matrices and species (not limited to human and murine). Furthermore, LC-MS proteomics sidesteps the potential interferences associated with antibody-based assays (such as the hook effect) while providing valuable insights into an additional dimension of proteomic complexity: post-translational modifications (PTMs).
We are proud to have successfully passed the Olink® certification test, further showcasing our professionalism and commitment to delivering high-quality and reliable data to our customers.
There is a vast universe of metabolites and lipids that also deserve exploration. If you are looking to get the most out of your samples through a multi-omics approach and maximize biological insights, our comprehensive services and expertise are here to support you.
Our targeted or untargeted metabolomics and lipidomics services are fully compatible with and seamlessly integrate into Olink® panels, ensuring a streamlined and efficient workflow. Whether you are interested in a broad spectrum or a focused analysis of specific molecules, we offer both technical and scientific support to meet your needs.
Thanks to our intuitive oloMAP Portal, we provide deeper insights into the metabolic pathways related to the proteins identified through Olink®, helping you unlock the full potential of your data.
At oloBion, we offer cutting-edge proteomics services to support researchers and industries, including Pharmaceutial & Biotechnology and Health & Medicine. With the support of Olink® Proximity Extension Assay (PEA) technology and the expertise of our team, we help you unlock the full potential of proteomics, enabling breakthrough discoveries, innovative solutions, and impactful applications. We are an official Olink® Certified Service Provider for Olink® Target and Olink® Flex products tailored to your specific needs.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. The assays in this panel include proteins involved in key biological processes such as cellular regulation, development, signal transduction and stress responses.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Oncology II features putative cancer-related human proteins that participate in biological mechanisms that are central to the initiation and progression of cancer, e.g. angiogenesis, cell-cell signaling, cell-cycle control, and inflammation.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Organ Damage features biomarkers involved in biological response to organ damage with a main focus on stress response, but also on regulation of cell proliferation, the cell cycle, and cell death/apoptosis.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Oncology III includes biomarkers involved in angiogenesis, cell communication, cellular metabolic processes, apoptosis and cell proliferation/differentiation. It is a perfect complement to our Olink® Target 96 Oncology II panel.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Inflammation features the most extensive commercially available biomarker selection for proteins associated with inflammatory diseases such as arthritis, chronic obstructive pulmonary disease, diabetes, psoriasis, and related biological processes. It is compiled to detect a selection of both established and exploratory biomarkers within the inflammation research field.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Metabolism includes biomarkers involved in cellular metabolic processes, cell surface receptor signaling pathways, regulation of phosphorylation and cell adhesion.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. The Olink® Target 96 Immuno-Oncology panel covers biomarkers related to immunotherapy/checkpoint molecules and biomarkers involved in promotion and inhibition of tumor immunity, chemotaxis, vascular & tissue remodeling, apoptosis & cell killing, and metabolism & autophagy.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Immune Response includes biomarkers involved in key biological processes such as adaptive immune response, defense response to viruses, lymphocyte activation, inflammatory responses and cytokine-mediated signaling pathways.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Cardiovascular II focuses on cardiovascular and inflammatory biomarkers which have been carefully selected in collaboration with leading experts in the field. It also includes a selection of exploratory proteins with potential as new CVD markers.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Neuro Exploratory consists of a combination of exploratory and established biomarkers with a focus on neurology-related diseases, and biological processes such as axon development, neurogenesis and synapse assembly. This panel is a good complement to Olink® Target 96 Neurology.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. The Olink® Target 96 Development panel focuses on biomarkers involved in cell communication and developmental processes.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Cell Regulation includes biomarkers involved in key biological processes such as cell communication, apoptotic processes, the cell cycle and cell differentiation.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. The Olink® Target 96 Neurology features well-established biomarkers related to neurobiological processes and neurological diseases (e.g. neural development, axon guidance, synaptic function, or specific conditions such as Alzheimer’s disease). Also includes additional exploratory proteins with broader roles in processes such as cellular regulation, immunology, development and metabolism.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Cardiometabolic features biomarkers involved in cellular metabolic processes, cell adhesion, immune response and complement activation. It is an excellent complement to Olink® Target 96 Cardiovascular II and Olink® Target 96 Cardiovascular III.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. As well as the cardiovascular, CVD, and exploratory protein markers included in Cardiovascular II, the Olink® Target 96 Cardiovascular III panel concentrates on cell adhesion biomarkers, carefully selected in collaboration with leading cardiovascular scientists.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 43 specific proteins. Olink® Target 48 Mouse Cytokine panel is a high-performance solution for protein multiplex studies in the murine model. The thorough selection of targeted biomarkers allows for a comprehensive view of the murine immune response, in-depth disease modelling and longitudinal studies in mice.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 44 specific proteins. Olink® Target 48 Immune Surveillance panel is a high-performance solution for immune response and inflammation-related studies. The carefully selected range of biomarkers in this panel provides a great mean for studying key pathways related to cytokine signalling, inflammatory processes, and immune response in cancer.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 45 specific proteins. Olink® Target 48 Cytokine panel is the high-performance solution for cytokine studies and inflammation-related diseases, with absolute or relative quantification. The thorough selection of biomarkers ensures that the most important proteins covering key pathways related to cytokine signaling and inflammatory processes are well covered.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 5 to 30 specific protein(s) selected from a library of 197 proteins, according to customer requirements.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 21 specific proteins. A panel targeting biomarkers involved in biological pathways central for immuno-oncology research e.g., angiogenesis, growth regulation, apoptosis and immunity.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 21 specific proteins. Assays carefully selected for their scientifically proven importance in the uncontrolled inflammatory response condition commonly referred to as cytokine storm.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 26 specific proteins. Includes 26 biomarkers crucial for studying inflammation and providing deeper insights into the immune landscape.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 21 specific proteins. Curated based on UK Biobank proteomics data to include top biomarkers associated with type 2 diabetes.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 21 specific proteins. Aging is a multifaceted process characterized by systemic chronic inflammation. This carefully curated panel includes biomarkers crucial in age-related changes of the immune system.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 20 specific proteins. Interferon (IFN) inflammation is associated with immunotherapy resistance in melanoma. This panel is developed together with Dr. Mehta and is based on findings from the Nature Immunology paper “In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer” (Manguso et al.)
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 5 specific proteins. Combines 5 key proinflammatory markers for targeted studies of inflammation and immune response.
Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout pg/mL.
Target Proteomics analysis for the identification of 21 specific proteins. This panel includes the most important cytokines characterizing the Th1/Th2/Th17 inflammatory profiles, thereby providing the ultimate solution for studies of the immune system.
More applications: Lipidomics | Metabolomics | Proteomics | ADME – DMPK | Bioinformatics | Ionomics | Caroteomics | Nutritional analysis
Statistical analysis and visualization of proteomics data
Integrate proteomics data with clinical, nutritional, or environmental datasets through the Correlation Module.
Expert interpretation to connect proteomics data with biological pathways and outcomes.
01
Contact and
Proposal
02
Send Samples
to the Lab
03
Sample Reception
and Processing
04
Mass Spectrometry
Analysis
05
Gain Insight into
oloMAP Portal
Standard Delivery Time:
6 weeks
Fast-track option available
Minimum Sample Amount:
Consult our experts for guidance
on sample requirements
Discount:
Associated with the number of
samples and multi-omics analysis
Partner with us to explore the power of protemics in your field. Our team is ready to guide you through the process and deliver insights tailored to your research or industry needs.
Contact us today to discuss your project or schedule a consultation. Together, we’ll advance innovation through proteomics!
